Treatment of Venous Malformations with Sclerosant in Microfoam Form

Archives of Dermatology

Volumn 139, Issue 11, 2003, Pages 1409-1416

  Cabrera, Juan ^a   Cabrera Jr , Juan ^a   Garcia Olmedo, Ma Antonia ^a   Redondo, Pedro ^b  

^a Vascular Surgery Clinic   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; SCLEROSING AGENT;

ADOLESCENT; ADULT; ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETER; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; FOLLOW UP; HEMOGLOBINURIA; HUMAN; INJECTION; INJECTION PAIN; LUNG EMBOLISM; MALE; MEDICAL RECORD; MOBILIZATION; MUSCLE WEAKNESS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PHOTOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROTHERAPY; SIDE EFFECT; SKIN NECROSIS; SKIN PIGMENTATION; THROMBOSIS; VEIN MALFORMATION;

ADOLESCENT; ADULT; AIR; FEMALE; HUMANS; KLIPPEL-TRENAUNAY-WEBER SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; MICROSPHERES; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VEINS;

EID: 0242408749     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.11.1409     Document Type: Article

References (26)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-420.
2. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell. 1996;87:1153-1155.
3. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375-423.
4. Mulliken JB, Young AE. Vascular Birthmarks: Hemangiomas and Malformations. Philadephia, Pa: WB Saunders Co; 1988.
5. Jacob AG, Driscoll DJ, Shaughnessy WJ, et al. Klippel-Trénaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28-36.
6. Baskerville PA, Akroyd JS, Thomas ML, Browse NL. The Klippel-Tré naunay syndrome: clinical, radiological, and hemodynamic features and management. Br J Surg. 1985;72:232-236.
7. Van der Stricht J. The sclerosing therapy in congenital vascular defects. Int Angiol. 1990;9:224-227.
8. Yakes WF, Luethke JM, Parker SH, et al. Ethanol embolization of vascular malformations. Radiographics. 1990;10:787-796.
9. de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg. 1995;30:188-194.
10. Jackson IT, Carreño R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993;91:1216-1230.
11. Goldman MP, Bennet RG. Treatment of telangiectasia: a review. J Am Acad Dermatol. 1987;17:167-182.
12. Dubois J, Sebag GH, De Prost Y, et al. The treatment of soft tissue venous malformation in children: percutaneous sclerotherapy with Ethibloc. Radiology. 1991;180:195-198.
13. Villavicencio JL. Primum non nocere: is it always true? the use of absolute ethanol in the management of congenital vascular malformations. J Vasc Surg. 2001;33:904-906.
14. Cabrera J, Cabrera J Jr, García-Olmedo MA. Elargissement des limites de la sclerotherapie: nouveaux produits sclerosants. Phlebologie. 1997;2:181-188.
15. Cabrera J, Cabrera J Jr, García-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes. Phebology. 2000;15:19-23.
16. Belov S. Late results in the treatment of vascular malformations. Int Angiol. 1998;7:136-143.
17. Weiss RA, Goldman MP. Advances in sclerotherapy. Dermatol Clin. 1995;13:431-445.
18. Cadere T. Treatment of varices with ethoxysclerol. Phlebologie. 1980;33:377-378.
19. Paul RE, Durant TM, Oppenheimer MJ, Stauffer HM. Intravenous carbon dioxide for intracardiac gas constrast in the roentgen diagnosis of pericardial effusion and thickening. Am J Roentgenol Radium Ther Nucl Med. 1957;78:224-225.
20. Meltzer RS, Serruys PW, Hugenholtz PG, Roelandt J. Intravenous carbon dioxide as an echocardiographic contrast agent. J Clin Ultrasound. 1981;9:127-131.
21. Bendib M, Toumi M, Boudjellab A. CO2 angiography and enlarged CO2 angiography in cardiology [in French]. Ann Radiol (Paris). 1977;20:673-686.
22. Fermand M, Marzelle J, Cormier F, Cormier JM. Aorto-arteriography of the lower limbs using carbon dioxide [in French]. Presse Med. 1994;23:19-22.
23. Martinez-Cuesta A, Elduayen B, Vivas I, Delgado C, Gonzalez-Crespo I, Bilbao JI. CO2 wedged hepatic venography technical considerations and comparison with direct and indirect portography with iodinated contrast. Abdom Imaging. 2000;25:576-582.
24. Bikerman JJ. Foams. New York, NY: Springer-Verlag; 1973.
25. Cabrera J, Cabrera J Jr, inventors; BTG International Limited, assignee. Injectable microfoam containing a sclerosing agent. US patent 5676962. October 16, 1997.
26. Cabrera J, Cabrera J Jr, inventors; BTG International Limited, assignee. Injectable microfoam containing a sclerosing agent. European patent EP 0656203B1. June 21, 1996. Spain patent 9301430. June 23, 1993.